Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-31

Clinical Trial Update: Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa [Phase 2]

View source ↗

Summary

A Phase 2 trial in Africa evaluating a combination of antiretrovirals and antibodies for HIV-1 infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1-infection | Phase 2 | Status: RECRUITING